About maxygen Products Science & Technology News Investors Careers Contact Us

Archive News

2006

December 5, 2006

Maxygen Announces Grant of Biofuels License to Codexis, Inc.

November 7, 2006

Maxygen's Next-Generation Interferon Alpha Enters Phase Ia Clinical Trial

November 1, 2006

Maxygen to Present at the Rodman & Renshaw 8th Annual Healthcare Conference and the ThinkEquity ThinkTank Summit

October 30, 2006

Maxygen Reports Third Quarter 2006 Financial Results

October 27, 2006

Maxygen to Receive $17.8 Million From Acquisition of Avidia by Amgen

October 24, 2006

Maxygen to Host Third Quarter 2006 Financial Results Conference Call on October 30, 2006

September 20, 2006

Maxygen to Present at the UBS 2006 Global Life Sciences Conference

September 5, 2006

Maxygen Initiates Phase I Clinical Trial for Maxy-G34

July 31, 2006

Maxygen Reports Second Quarter 2006 Financial Results

July 18, 2006

Maxygen to Host Second Quarter 2006 Financial Results Conference Call on July 31, 2006

June 7, 2006

Maxygen to Present at the Goldman Sachs Healthcare Conference

May 9, 2006

Maxygen Achieves Milestone in Alliance with Roche for Factor VIIa Therapeutics

April 25, 2006

Maxygen Reports First Quarter 2006 Financial Results

March 1, 2006

Maxygen to Present at the Cowen & Co. 26th Annual Health Care Conference and the Lehman Brothers Ninth Annual Global Healthcare Conference

February 8, 2006

Maxygen to Present at the BIO CEO & Investor Conference

February 8, 2006

Maxygen Reports Fourth Quarter and Year End 2005 Financial Results

January 30, 2006

Maxygen to Host Fourth Quarter and Year End 2005 Financial Results Conference Call on February 8, 2006

January 5, 2006

Maxygen to Present at the JP Morgan 24th Annual Healthcare Conference

Return to News